We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds

By LabMedica International staff writers
Posted on 29 Mar 2023
Print article
Image: INSTI Multiplex HIV-1/2 Syphilis Antibody Test provides results for two infections with only one sample (Photo courtesy of bioLytical)
Image: INSTI Multiplex HIV-1/2 Syphilis Antibody Test provides results for two infections with only one sample (Photo courtesy of bioLytical)

HIV and syphilis co-infection is a significant health concern affecting individuals worldwide. Now, a new test is designed to detect antibodies for both HIV-1/2 and syphilis using a single sample obtained through a simple fingerprick method. This test delivers accurate results in under a minute, while being mobile and easy to use. Healthcare professionals can now test individuals in various environments, providing flexible options for those facing barriers to accessing healthcare. The test represents a powerful tool for identifying individuals who require treatment for HIV and/or syphilis, preventing mother-to-child transmission, and reducing the worldwide spread of both infections.

The INSTI Multiplex HIV-1/2 Syphilis Antibody Test from bioLytical Laboratories Inc. (Richmond, BC, Canada) simplifies the testing process by providing results for two infections using just one sample. This innovative approach reduces test anxiety for patients and allows healthcare professionals to test more people in less time. The INSTI Multiplex HIV-1/2 Syphilis Antibody Test has been developed by bioLytical using its proprietary INSTI technology. The portable test is designed for professional use in point-of-care settings but can be performed in a variety of other settings and offers easy-to-understand results.

Clinical studies have shown that the test has a high level of accuracy, with sensitivity and specificity that outperform other tests in the industry. A study the importance of regular and frequent testing to help connect patients to care demonstrated that the real-time results provided by the INSTI platform enabled healthcare professionals to connect patients who tested positive for HIV to care, and the majority of those who tested positive for active syphilis (87.4%) were treated immediately after the point-of-care test results, while the remaining participants were treated within a median of four days.

The INSTI Multiplex HIV-1/2 Syphilis Antibody Test, which has been in use in Europe and Africa since 2016, has now been approved for use in Canada. With syphilis infection rates in Canada reaching unprecedented levels, having increased by 166% nationwide between 2017 and 2021, the approval of this test is a crucial step in addressing this public health issue. Despite decreased access to STBBI services during the pandemic, new infections have continued to increase by 20% between 2020 and 2021 across all demographics. The authorization of the INSTI Multiplex HIV-1/2 Syphilis Antibody Test for professional use in point-of-care settings will provide Canadians with easier access to early testing in various settings, regardless of their demographic.

Related Links:
bioLytical Laboratories 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.